Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
Mult Scler Relat Disord
; 43: 102222, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-343145
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Multiple Sclerosis, Relapsing-Remitting
/
Antibodies, Monoclonal, Humanized
/
Immunologic Factors
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Mult Scler Relat Disord
Year:
2020
Document Type:
Article
Affiliation country:
J.msard.2020.102222
Similar
MEDLINE
...
LILACS
LIS